M.F. Mosele
Inserm(FR)Inserm(FR)Institut Gustave Roussy(FR)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, Genetic factors in colorectal cancer, Advanced Breast Cancer Therapies
Most-Cited Works
- → Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group(2024)284 cited
- → Liquid Biopsy versus CT: Comparison of Tumor Burden Quantification in 1065 Patients with Metastases(2024)14 cited
- → Patritumab deruxtecan in HR+HER2− advanced breast cancer: a phase 2 trial(2025)5 cited
- → Corrigendum to “Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group”(2025)2 cited
- → Patritumab deruxtecan in breast cancer treatment: a drug evaluation(2025)1 cited
- → Author Correction: Characterization and spatial distribution of infiltrating lymphocytes in medullary, and lymphocyte-predominant triple negative breast cancers(2024)
- → ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer(2025)
- → 3200eP PRISM platform for exceptional genomic cases (PPEGC): A real-time platform to capture and disseminate data from exceptional cases in oncology(2025)